IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,304,541 | -43.9% | 1,900,783 | -38.1% | 0.00% | -33.3% |
Q2 2023 | $32,647,126 | -18.3% | 3,068,339 | -19.2% | 0.00% | -25.0% |
Q1 2023 | $39,965,405 | +21.3% | 3,798,993 | +42.9% | 0.00% | 0.0% |
Q4 2022 | $32,938,902 | +44.3% | 2,658,507 | +20.7% | 0.00% | +33.3% |
Q3 2022 | $22,829,000 | -23.2% | 2,203,402 | -14.5% | 0.00% | -25.0% |
Q2 2022 | $29,721,000 | +3.4% | 2,577,531 | +12.9% | 0.00% | 0.0% |
Q1 2022 | $28,731,000 | +133.9% | 2,283,824 | +116.8% | 0.00% | +100.0% |
Q4 2021 | $12,282,000 | -44.9% | 1,053,422 | -38.3% | 0.00% | -33.3% |
Q3 2021 | $22,304,000 | +19.2% | 1,707,789 | +17.4% | 0.00% | +50.0% |
Q2 2021 | $18,715,000 | +66.6% | 1,454,153 | +44.7% | 0.00% | 0.0% |
Q1 2021 | $11,234,000 | -22.3% | 1,004,793 | -20.8% | 0.00% | 0.0% |
Q4 2020 | $14,449,000 | +79.6% | 1,268,521 | +41.8% | 0.00% | 0.0% |
Q3 2020 | $8,047,000 | +525.7% | 894,711 | +617.9% | 0.00% | – |
Q2 2020 | $1,286,000 | +153.1% | 124,633 | +147.6% | 0.00% | – |
Q1 2020 | $508,000 | -87.4% | 50,339 | -83.4% | 0.00% | -100.0% |
Q4 2019 | $4,034,000 | +286.0% | 303,060 | +149.2% | 0.00% | – |
Q3 2019 | $1,045,000 | +5.8% | 121,595 | +34.7% | 0.00% | – |
Q2 2019 | $988,000 | -81.5% | 90,293 | -77.1% | 0.00% | -100.0% |
Q1 2019 | $5,335,000 | -30.1% | 394,334 | -46.5% | 0.00% | 0.0% |
Q4 2018 | $7,637,000 | +60.6% | 737,128 | +186.1% | 0.00% | +100.0% |
Q3 2018 | $4,755,000 | -31.1% | 257,608 | -28.6% | 0.00% | -50.0% |
Q2 2018 | $6,903,000 | +32.6% | 361,036 | +7.0% | 0.00% | +100.0% |
Q1 2018 | $5,205,000 | +10.7% | 337,345 | +7.5% | 0.00% | 0.0% |
Q4 2017 | $4,704,000 | +24.7% | 313,795 | +31.1% | 0.00% | 0.0% |
Q3 2017 | $3,773,000 | +10.5% | 239,306 | +32.3% | 0.00% | 0.0% |
Q2 2017 | $3,416,000 | -53.9% | 180,942 | -58.4% | 0.00% | 0.0% |
Q1 2017 | $7,412,000 | -49.4% | 434,456 | -54.7% | 0.00% | -50.0% |
Q4 2016 | $14,658,000 | +496.8% | 958,760 | +519.9% | 0.00% | +100.0% |
Q3 2016 | $2,456,000 | +9.5% | 154,653 | -9.9% | 0.00% | 0.0% |
Q2 2016 | $2,243,000 | -57.7% | 171,596 | -64.6% | 0.00% | -50.0% |
Q1 2016 | $5,297,000 | -52.6% | 484,217 | -49.8% | 0.00% | -50.0% |
Q4 2015 | $11,170,000 | +5.8% | 963,822 | -4.9% | 0.00% | 0.0% |
Q3 2015 | $10,560,000 | -86.1% | 1,013,524 | -83.9% | 0.00% | -84.6% |
Q2 2015 | $76,143,000 | -33.7% | 6,313,653 | -12.1% | 0.03% | -38.1% |
Q1 2015 | $114,871,000 | -3.0% | 7,179,439 | -7.1% | 0.04% | -2.3% |
Q4 2014 | $118,374,000 | +13.4% | 7,726,761 | -4.1% | 0.04% | +7.5% |
Q3 2014 | $104,343,000 | -15.8% | 8,054,267 | -0.4% | 0.04% | -18.4% |
Q2 2014 | $123,929,000 | +23.7% | 8,084,120 | -0.6% | 0.05% | +16.7% |
Q1 2014 | $100,150,000 | +3.0% | 8,129,015 | -3.0% | 0.04% | +2.4% |
Q4 2013 | $97,280,000 | -13.8% | 8,378,965 | -12.1% | 0.04% | -22.6% |
Q3 2013 | $112,865,000 | +16.9% | 9,532,505 | -1.9% | 0.05% | +8.2% |
Q2 2013 | $96,520,000 | – | 9,720,209 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |